Home > Balance Sheet > GLAND PHARMA

GLAND PHARMA
Sundry Debtors

    Back to Balance Sheet
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Sundry Debtors History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Sundry Debtors ₹1,891 Cr₹1,517 Cr₹1,559 Cr₹871 Cr₹1,075 Cr

What is the latest Sundry Debtors ratio of GLAND PHARMA ?

The latest Sundry Debtors ratio of GLAND PHARMA is ₹1,891 Cr based on Mar2026 Consolidated results.
Year Sundry Debtors
Mar2026₹1,891 Cr
Mar2025₹1,517 Cr
Mar2024₹1,559 Cr
Mar2023₹871 Cr
Mar2022₹1,075 Cr

How is Sundry Debtors of GLAND PHARMA Trending?

Years Sundry Debtors % Change
Mar2026 ₹1,891 Cr
24.72
Mar2025 ₹1,517 Cr
-2.70
Mar2024 ₹1,559 Cr
78.87
Mar2023 ₹871 Cr
-18.93
Mar2022 ₹1,075 Cr -

Compare Sundry Debtors of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹49,949.6 Cr -2% 4% 57.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,684.0 Cr -1.4% -6.5% 5.5% Stock Analytics
DIVIS LABORATORIES ₹241,311.0 Cr -2% -2.7% 40.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹173,079.0 Cr -1.8% -7% 29.6% Stock Analytics
CIPLA ₹107,528.0 Cr 0.1% -3% -15.3% Stock Analytics
DR REDDYS LABORATORIES ₹103,667.0 Cr 0.2% 6% -2.4% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-2%

4%

57.8%

SENSEX

2.7%

-0.7%

-10.5%


You may also like the below Video Courses